| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.38 | 7e-09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |